Value, Access, and Regulatory Strategy Conference

pharmafile | September 4, 2018 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, London, Regulatory Strategy, access, dia 

Tuesday, October 09, 2018 – Wednesday, October 10, 2018
Renaissance London Heathrow Hotel, UK
See Map

Learn more about the event here
Register for the event here

Event Type: Conference

Europe is facing challenging discussions related to affordability and patient access. Ongoing collaboration activities between national HTAs and between HTAs and Regulators hold some promise for better alignment of requirements that will allow more predictable assessment outcomes in Europe. Stakeholders have started to dialogue across disciplines and legislators are proposing new instruments to set up a sustainable system for EU collaboration on clinical value assessments.

“DIA’s Value, Access, and Regulatory Strategy Conference provides the only forum for open, interactive dialogue between policy makers, payers, HTA bodies, and other stakeholders, for discussing short-term strategies and long-term market solutions.” Solange Corriol-Rohou, DrMed, Md, PhD, Senior Director, Speaker at the event, Global Regulatory Affairs & Policy, Europe, AstraZeneca, Global Medicines Development, France

Related Content

researchers_credit_neusentis_pfizer

Ambitious plans for leading cancer research centre announced

Aviva Capital Partners (ACP), an infrastructure and real estate investor, and Socius, a mixed-use developer, …

FlyPharma Europe, Vienna – 23-24 October 2024 conference

Samedan announces that on 23-24 October 2024, their FlyPharma Conference will make a welcome return …

Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London

Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has …

The Gateway to Local Adoption Series

Latest content